BCLC™ AKG-PQQ-Agaricus bisporus Triad for Mitochondrial Function Support: Formulation Engineering and Evidence in Senescent Hepatocytes
International Journal of Agriculture and Food Sciences Research · 29.04.2026 · 4 (1) · 61-66
DOI: 10.62051/ijafsr.v4n1.05 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Agriculture and Food Sciences Research, online erschienen am 29.04.2026. Verfasst von Nour-Eddine Ziraoui und 3 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Mitochondrial dysfunction is increasingly recognized as a central feature of cellular senescence and age-related functional decline [1,2].
Objective
We evaluated a ratio-defined triad containing alpha-ketoglutarate (AKG), pyrroloquinoline quinone disodium (PQQ), and Agaricus bisporus extract, and we aligned the formulation dataset with published mechanistic and human evidence relevant to mitochondrial support.
Methods
We summarized composition windows, post-processing retention, and 48 h senescent-hepatocyte readouts, then compared these data with peer-reviewed studies on mitochondrial biogenesis, redox control, and mushroom-derived ergothioneine bioavailability [3-13].
Results
Across the three embodiments, AKG and PQQ retention remained high after processing (98.6-99.2%), while the comparative formula showed lower retention (92.2-92.8%). In senescent hepatocytes, the comparative formula showed lower membrane potential (52.3-65.2% of embodiment values) and higher mitochondrial reactive oxygen species (2.1-2.5-fold versus embodiments). Public evidence supported the mechanistic plausibility of the triad: PQQ has repeatedly been linked with mitochondrial biogenesis signaling [3-8]; AKG has shown protection against mitochondrial dysfunction and oxidative stress in hepatocyte-based models [9]; and ergothioneine from A. bisporus is bioavailable in humans and is increasingly linked with oxidative-stress resilience [11-13].
Conclusion
The triad shows coherent formulation-performance characteristics and biologically plausible multi-target activity, but dedicated human trials of the specific combined system are still required.
Zitieren
APA
Ziraoui, N., Mendoza, R., Harrington, V., & Carter, S. (2026). BCLC™ AKG-PQQ-Agaricus bisporus Triad for Mitochondrial Function Support: Formulation Engineering and Evidence in Senescent Hepatocytes. International Journal of Agriculture and Food Sciences Research, 4(1), 61-66. https://doi.org/10.62051/ijafsr.v4n1.05
Vancouver
Ziraoui N, Mendoza R, Harrington V, Carter S. BCLC™ AKG-PQQ-Agaricus bisporus Triad for Mitochondrial Function Support: Formulation Engineering and Evidence in Senescent Hepatocytes. International Journal of Agriculture and Food Sciences Research. 2026;4(1):61-66. doi:10.62051/ijafsr.v4n1.05
BibTeX
@article{Ziraoui2026,
author = {Ziraoui, Nour-Eddine and Mendoza, Rafael and Harrington, Victoria and Carter, Sofia},
title = {BCLC™ AKG-PQQ-Agaricus bisporus Triad for Mitochondrial Function Support: Formulation Engineering and Evidence in Senescent Hepatocytes},
journal = {International Journal of Agriculture and Food Sciences Research},
year = {2026},
volume = {4},
number = {1},
pages = {61--66},
doi = {10.62051/ijafsr.v4n1.05}
}
EUVIMED